Literature DB >> 29411144

Olfactory Neuroblastoma.

Ahmed S Abdelmeguid1,2.   

Abstract

PURPOSE OF REVIEW: To provide a comprehensive review of the literature focusing on the recent advances in the diagnosis and management of olfactory neuroblastoma. RECENT
FINDINGS: Multimodality treatment is usually recommended for the majority of ONB cases. Recent advances in surgical approaches include the evolving role of endonasal endoscopic surgical resection and reconstruction. The introduction of new conformal radiation techniques has improved the outcomes and reduced treatment-related toxicity to important structures such as the eye and the brain. The role of neoadjuvant and adjuvant chemotherapy is yet to be defined. In the last two decades, there have been advances in surgical techniques with endoscopic approaches, either alone or in combination with craniotomy, gradually replacing the open traditional approaches. Prolonged surveillance is recommended for ONB due to late recurrences associated with that tumor. The role of chemotherapy and elective neck irradiation is still controversial and needs more studies to investigate their optimal role.

Entities:  

Keywords:  Endoscopic resection; Esthesioneuroblastoma; Olfactory neuroblastoma; Sinonasal; Skull base

Mesh:

Year:  2018        PMID: 29411144     DOI: 10.1007/s11912-018-0661-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  46 in total

1.  Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion.

Authors:  Y López Plasencia; M Boronat Cortés; D Marrero Arencibia; T Montenegro Dámaso; I Lisner Contreras; A Ojeda Pino; A Carrillo Domínguez; F La Roche Brier; Y García Delgado; F J Nóvoa Mogollón
Journal:  Head Neck       Date:  2006-12       Impact factor: 3.147

2.  Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol.

Authors:  Joanne Rimmer; Valerie J Lund; Timothy Beale; William I Wei; David Howard
Journal:  Laryngoscope       Date:  2014-02-04       Impact factor: 3.325

3.  Esthesioneuroblastoma: is there a need for elective neck treatment?

Authors:  Candan Demiroz; Orit Gutfeld; Mohamed Aboziada; Doris Brown; Lawrence J Marentette; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-15       Impact factor: 7.038

4.  Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy.

Authors:  Maria Suriano; Marco De Vincentiis; Alessandro Colli; Guido Benfari; Alberto Mascelli; Andrea Gallo
Journal:  Otolaryngol Head Neck Surg       Date:  2007-01       Impact factor: 3.497

Review 5.  Endoscopic resection of sinonasal cancers.

Authors:  Shirley Y Su; Michael E Kupferman; Franco DeMonte; Nicholas B Levine; Shaan M Raza; Ehab Y Hanna
Journal:  Curr Oncol Rep       Date:  2014-02       Impact factor: 5.075

6.  Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.

Authors:  Eduardo M Diaz; Richard H Johnigan; Colin Pero; Adel K El-Naggar; Dianna B Roberts; James L Barker; Franco DeMonte
Journal:  Head Neck       Date:  2005-02       Impact factor: 3.147

7.  Olfactory neuroblastoma: past, present, and future?

Authors:  Valerie J Lund; David Howard; William Wei; Margaret Spittle
Journal:  Laryngoscope       Date:  2003-03       Impact factor: 3.325

8.  Esthesioneuroblastoma: prognosis and management.

Authors:  A Morita; M J Ebersold; K D Olsen; R L Foote; J E Lewis; L M Quast
Journal:  Neurosurgery       Date:  1993-05       Impact factor: 4.654

9.  Proton-beam therapy for olfactory neuroblastoma.

Authors:  Hideki Nishimura; Takashi Ogino; Mitsuhiko Kawashima; Keiji Nihei; Satoko Arahira; Masakatsu Onozawa; Shoichi Katsuta; Teiji Nishio
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-29       Impact factor: 7.038

Review 10.  Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment.

Authors:  Shirley Y Su; Diana Bell; Ehab Y Hanna
Journal:  Int Arch Otorhinolaryngol       Date:  2014-10
View more
  9 in total

1.  [68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases.

Authors:  Michelle Roytman; Andrew B Tassler; Ashutosh Kacker; Theodore H Schwartz; Georgiana A Dobri; Sara B Strauss; Alyssa M Capalbo; Rajiv S Magge; Marissa Barbaro; Eaton Lin; Joseph R Osborne
Journal:  J Neurosurg Case Lessons       Date:  2021-01-11

2.  Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma.

Authors:  Jingyi Yang; Xiaole Song; Yuting Lai; Weidong Zhao; Jiaying Zhou; Quan Liu; Wanpeng Li; Huankang Zhang; Huan Wang; Peng Shi; Hongmeng Yu; Xicai Sun; Dehui Wang
Journal:  EClinicalMedicine       Date:  2020-11-30

3.  Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation.

Authors:  Marianne Spengler; Megan Wheelden; Heath B Mackley; Joseph J Drabick
Journal:  JCO Precis Oncol       Date:  2021-04-19

4.  Management of orbital invasion in esthesioneuroblastoma: 14 years' experience.

Authors:  Ruichen Li; Shu Tian; Yi Zhu; Li Yan; Wenjia Zhu; Huatao Quan; Shengzi Wang
Journal:  Radiat Oncol       Date:  2019-06-13       Impact factor: 3.481

5.  Olfactory neuroblastoma resection through endoscopic endonasal approach: A rare case report.

Authors:  Yogi Putra Adhi Pradana; Budi Sutikno
Journal:  Ann Med Surg (Lond)       Date:  2022-01-04

6.  Management of Esthesioneuroblastoma: A Retrospective Study of 6 Cases and Literature Review.

Authors:  Zenab Alami; Fatima Zahrae Farhane; Amina Bouziane; Samiya Mhirech; Sara Amrani Joutei; Wissal Hassani; Touria Bouhafa
Journal:  Case Rep Oncol       Date:  2022-03-10

7.  Olfactory Neuroblastoma Managed with Endoscopic Sinus Surgery.

Authors:  Saleh Mayoof Al-Osaimi; Althumali Abdulaziz Hameed; Atheer Abdulraheem Alsufyani; Rahaf Ghazi Altwairqi; Abrar Fahad Alotaibi
Journal:  J Pharm Bioallied Sci       Date:  2021-11-10

8.  Synergistic Effect of Statins and Abiraterone Acetate on the Growth Inhibition of Neuroblastoma via Targeting Androgen Receptor.

Authors:  Zengchun Hu; Chuandong Cheng; Yue Wang; Tianrui Chen; Junhong Tu; Chaoshi Niu; Rong Xing; Yang Wang; Yinghui Xu
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

9.  The Treatment Outcomes of Olfactory Neuroblastoma Patients With Frontal Lobe Invasion.

Authors:  Jie Wang; Li Wang; Huanyu He; Yi Li; Xinmao Song
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.